Young Tanzanians who have completed secondary school and degree holders are invited to apply for job opportunities as Fire ...

The opioid epidemic costs the U.S. over $1.5 trillion annually, overloading hospitals, public health systems, and law ...

Dr Siyab Panhwar, a cardiologist at NYU Langone in New York City, says there are three drugs that he would never touch ...

Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...

A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

PF614-MPAR over 4.5 days. The aggregation of interim data allows the Company to focus on perfecting a final drug product to move to commercialization. Dr. Bill Schmidt, Chief Medical Officer of ...

Outpatient low-dose buprenorphine initiation in fentanyl users with opioid use disorder showed both low success and low ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

We thank the NIDA Drug Supply Program (Bethesda, MD) for supplying us with LSD-tartrate. We thank Mitchell Huffstickler, Christopher Means, Julia Hoyt, Sarah Page Steffens, Ann Njoroge, and Nathan ...

Only a tiny percentage of people addicted to alcohol or drugs take medication for it. Why not? It's complicated, but the approved medications are not blockbusters for alcohol use disorder.

The development of the drug has been supported by a $14 million award from the National Institute on Drug Abuse (NIDA). The ongoing ... including a $5 million financing transaction and a $14 ...